SCHEMBL32688192

SCHEMBL32688192

N#Cc1c(-c2ccccc2C(=O)O)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MEN1 O00255 2/20 0.38
▸ LMNA P02545 3/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ PKM P14618 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD11B1 P28845 5/20 0.35
▸ ACMSD Q8TDX5 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ BRS3 P32247 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687977 0.89 KMT2A (0.39) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL32688138 0.84 KMT2A (0.41) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL32688247 0.83 ACMSD (0.44) ALDH1A1KMT2AHPGDACMSD
SCHEMBL32687986 0.82 KMT2A (0.39) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL32688004 0.80 KMT2A (0.38) ALDH1A1KMT2AHPGDMEN1KDM4E
SCHEMBL32688056 0.79 MET (0.41) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL32687966 0.78 BCL6 (0.38) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL32688271 0.78 ALDH1A1 (0.42) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL26404230 0.77 ALDH1A1 (0.56) ALDH1A1KMT2AHPGDMEN1LMNA
SCHEMBL32688199 0.76 HSD11B1 (0.36) ALDH1A1KMT2AHPGDMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885KMT2A 3400/4885HPGD 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback